Diarrhea: all 865 studies

Page 4 of 9. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.CompletedNCT05226052Not applicable
• HIV Indicator Diseases in Hospital and Primary CareStatus unknownNCT05225493
• Anti-Secretory Drug in Treatment of Acute Watery DiarrheaCompletedNCT05216822Phase 1
• Evaluation of Serum Interleukin 6 and 8 in Children With Acute GastroenteritisStatus unknownNCT05213325
• Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea PredominantCompletedNCT05207618Not applicable
• Effects of "For-Baby" Supplementation on Young Children's Physical Growth and Diarrhea EpisodesStatus unknownNCT05185973Not applicable
• IL6&8 in Malnourished Children With Acute DiarrheaStatus unknownNCT05183789
• GOS to Reduce Symptom Severity in IBSCompletedNCT05157061Not applicable
• Liberia National Community Health Assistant (NCHA) Program and Under-five MortalityStatus unknownNCT05123378Not applicable
• Monitoring the Effects of Probiotic Supplementation in Immunocompromised Kidney Transplanted SubjectsWithdrawnNCT05102461Not applicable
• The Efficacy of Asacol (Mesalazine) Suppository on the Treatment of Diarrhea-Induced Acute FissureCompletedNCT05091775Phase 1/2
• Registry and Clinical Observation of Children With Diarrhoeal DiseaseStatus unknownNCT05052489
• Validation of a CDSA Strategy to Reduce Antibiotic Prescription in SenegalCompletedNCT05050825Not applicable
• A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast CancerStatus unknownNCT05030519
• The Impact of a School-based WASH Intervention on Child Health and School Attendance in Addis Ababa, EthiopiaCompletedNCT05024890Not applicable
• Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™CompletedNCT05008640
• Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five YearsCompletedNCT05002101Phase 4
• Clinical Study on Prevention and Treatment of Pyrotinib Associated Diarrhea With Traditional Chinese MedicineStatus unknownNCT04988165Phase 2
• To Study the Efficacy and Safety of L. Plantarum UALp-05TM in Diarrhea- Predominant-irritable Bowel SyndromeCompletedNCT04950296Not applicable
• XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)CompletedNCT04926545Not applicable
• Faecal Microbiota Transplantation in Irritable Bowel SyndromeCompletedNCT04899869Not applicable
• Effect of Lactibiane Tolerance® to Treat Leaky Gut in Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)PatientsCompletedNCT04898257Not applicable
• Comparing the Efficacy of Anti-secretory Versus Oral Immunoglobulins for Reducing the Episodes of Diarrhea in ChildrenStatus unknownNCT04885049Not applicable
• Effect of the Use of Symbiotics in Patients With Colon CancerStatus unknownNCT04874883Phase 4
• An Epidemiological Surveillance Study to Determine the Incidence of ETEC in Children and Infants in LusakaCompletedNCT04838587
• Combined Lactobacilli (Reuteri LMG P-27481 and GG ATCC 53103) to Prevent Antibiotic Associated Symptoms in ChildrenStatus unknownNCT04836013Not applicable
• Wells and Enteric Disease TransmissionActive, not recruitingNCT04826991Not applicable
• The Effects of Bifidobacterium Breve Bif195 for Diarrhea-predominant Irritable Bowel SyndromeCompletedNCT04808271Not applicable
• Comparison Of Outcome Of Lactose Free Formula Milk With Yogurt In Children With Acute DiarrheaCompletedNCT04796480Not applicable
• Effectiveness of Folic Acid Supplementation in Acute Watery Diarrhea Among Children Under 5 Years of AgeStatus unknownNCT04782037Phase 4
• Prevention and Treatment of Pyrrolitinib-associated DiarrheaStatus unknownNCT04736186Phase 2/3
• Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat EthylWithdrawnNCT04713202Phase 2
• Assessment and Validation of Electronic Gas and Bloating DiaryStatus unknownNCT04684849
• Efficacy and Safety of "VS002A" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young ChildrenCompletedNCT04677296Not applicable
• Multi Strain Probiotic Preparation in Patients With Irritable Bowel SyndromeCompletedNCT04662957Not applicable
• Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in AfricaCompletedNCT04658914Phase 2
• IVC Index in Patient With Diarrhea and Dehydration And How It Affects Its ManagementStatus unknownNCT04654832
• Effect and Tolerability of Lactobacillus Rhamnosus GG LA801 for the Preventive Nutritional Care of Nosocomial Diarrhea in ChildrenTerminatedNCT04628819Not applicable
• Trial to Evaluate Dietary Supplements to Maintain Gut Health During TravelCompletedNCT04605783Not applicable
• The Acceptability and Impact of Diarrheal Etiology Prediction (DEP) AlgorithmCompletedNCT04602676Not applicable
• Poultry Management and Child Diarrhea in UgandaCompletedNCT04580212Not applicable
• COVID-19 Disease Duration and GIT Manifestations. A New Disease Severity Classification. An Egyptian ExperienceCompletedNCT04554979
• Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer TherapyCompletedNCT04538625Phase 3
• Efficacy and Safety of Changkang Granule in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT04492787Phase 2
• Fecal Calprotectin Level in Patients With Nosocomial DiarrheaCompletedNCT04491799
• Efficacy and Safety of a Food Supplement With Standardized Menthol, Limonene, and Gingerol Content in Patients With Irritable Bowel SyndromeCompletedNCT04484467Not applicable
• Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal TumorsWithdrawnNCT04447443Not applicable
• Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)CompletedNCT04423159Not applicable
• Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable
• Bacteriotherapy in the Treatment of COVID-19Status unknownNCT04368351
• Investigation of Eluxadoline for Diabetic DiarrheaWithdrawnNCT04313088Phase 2/3
• A Baseline Study in Support of Clinical Evaluation of an Oral Shigella Vaccine Development in AfricaCompletedNCT04312906
• Efficacy and Safety of Modified Gegen Qinlian Decoction for Diarrhea-predominant Irritable Boewl SyndromeStatus unknownNCT04312477Early Phase 1
• L Rhamnosus ATCC 53103 & L Reuteri DSM 29063 Compared With L Rhamnosus ATCC 53103 for Preventing AAD in ChildrenStatus unknownNCT04277156Not applicable
• The Utility of Biofire Filmarray in Evaluation of Entero Pathogens Triggers in Patients With Chronic DiarrheaStatus unknownNCT04269174
• Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in NewbornsCompletedNCT04262648Not applicable
• Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized PatientsWithdrawnNCT04246151Early Phase 1
• Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ERCompletedNCT04237181Not applicable
• A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBSWithdrawnNCT04214470
• Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)CompletedNCT04212403Not applicable
• Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious DiarrheaCompletedNCT04192487Phase 4
• MTT for Children With ASD Who Have Gastrointestinal DisordersActive, not recruitingNCT04182633Phase 2
• Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic TherapyCompletedNCT04171466Not applicable
• Antibiotic-Associated Diarrhea and the Role of Microorganisms in the GutCompletedNCT04156555Phase 4
• Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in UgandaCompletedNCT04144491Not applicable
• G-PUR® for Symptomatic Treatment in Irritable Bowel Syndrome With DiarrheaStatus unknownNCT04138186Not applicable
• Phase 2/3 Study to Evaluate PK, Safety & Efficacy of INM004 in STEC Positive Pediatric Patients for Prevention of HUSTerminatedNCT04132375Phase 2/3
• A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedNCT04129619Phase 2
• Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)Status unknownNCT04095988Not applicable
• Effect of Bacillus Subtilis DE111® on Daily Bowel MovementsCompletedNCT04083521Not applicable
• Clinical Trial in Children Between 3 Months and 14 Years Old to Evaluate the Efficacy and Safety of Gelatin Tannate in the Treatment of Acute Diarrhea (INDIGO)CompletedNCT04065529Phase 3
• Efficiency and Safety of Zinc Sulphate to Reduce the Duration of Acute Diarrheal Disease Between 6 and 59 Months of AgeCompletedNCT04061538Not applicable
• To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With RegurgitationCompletedNCT04042454Not applicable
• Fecal Microbiota Transplantation in Diarrhea Induced by Tyrosine-kinase InhibitorsCompletedNCT04040712Not applicable
• Zinc Sulfate AcceptabilityCompletedNCT04039828Not applicable
• Drinking Water Chlorination and Child Survival in Rural KenyaCompletedNCT04020965Not applicable
• Gastrointestinal Dysfunction During Enteral Nutrition in Critically Ill PatientsCompletedNCT04014816
• Cholera-Hospital-Based-Intervention-for-7-daysCompletedNCT04008134Not applicable
• The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending ColonCompletedNCT04003181Not applicable
• A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS SymptomsCompletedNCT03997708Not applicable
• A Nutritional Trial on Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in UgandaStatus unknownNCT03990220
• The Effectiveness of Pleuran in Treatment of Acute Gastroenteritis in ChildrenCompletedNCT03988257Phase 4
• Prevention of Radiotherapy Induced Enteropathy by Probiotics (PREP)Status unknownNCT03978949Phase 3
• Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican RepublicCompletedNCT03972618Not applicable
• Clostridium Difficile Infection (CDI) in Hematologic Patients.Status unknownNCT03964844
• Improving Nighttime Access to Care and Treatment (Part 2)CompletedNCT03943654
• Effect of the Sequestrant Colesevelam in Bile Acid DiarrhoeaCompletedNCT03876717Phase 4
• Clinical Evaluation of the Use of an mHealth Intervention on Quality of CareCompletedNCT03874143Not applicable
• ESBL in Patients Returning to Sweden With Traveller's DiarrhoeaCompletedNCT03866291
• Ciprofloxacin Versus Azithromycin for Children Hospitalised With DysenteryCompletedNCT03854929Phase 4
• Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritisCompletedNCT03851835Phase 3
• Mode of Action of Ondansetron, a 5-HT Receptor 3 Antagonist, in Lactulose Induced DiarrhoeaCompletedNCT03833999Phase 4
• Health Promotion Intervention to Reduce Child MorbidityCompletedNCT03810430Not applicable
• Interest of Pan Capsule in Symptomatic Patients Suspected of Irritable Bowel Syndrome Requiring ColonoscopyCompletedNCT03806959Not applicable
• Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile InfectionCompletedNCT03806803Phase 2
• A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated DiarrheaTerminatedNCT03793686Phase 1
• Multidrug Resistant Shigella Infection in BangladeshStatus unknownNCT03778125
• Prevention of Diarrheal Disease Due to Infection With Enterotoxigenic E. Coli (ETEC)CompletedNCT03729219Phase 2
• Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETsCompletedNCT03722511Phase 2
• Software Interventions for Improving Hand Washing and Sanitation in Rural Tanzania: an Impact EvaluationCompletedNCT03709368Not applicable

← Diarrhea overview